## CCEP: Coca-Cola Europacific Partners PLC - XLP: Consumer Defensive

### Executive Summary

VALUE thesis: PEG 1.48 indicates fundamental undervaluation. Quality metrics strong (ROE 18%). Caution: momentum weakening (-4.2% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($87.49)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Coca-Cola Europacific Partners $CCEP Stake Cut by Groupe la Francaise**
- Source: MarketBeat | 20251205T051237 | Somewhat-Bullish | Relevance: 100%
- Groupe la Francaise significantly reduced its stake in Coca-Cola Europacific Partners, selling 43,566 shares and retaining 16,745 shares. Despite this, other institutions like Vanguard, Norges Bank, and Nuveen increased or established new positions, bringing institutional ownership to 31.35%. Analysts maintain a "Moderate Buy" rating with an average target price of $99.33 for CCEP stock.

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 16.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 1 |

**Top Holders:**
- Invesco Ltd.: 3.5% (+31.6%)
- Blackrock Inc.: 3.4% (-1.3%)
- Vanguard Group Inc: 2.4% (+2.6%)
- Goldman Sachs Group : 1.5% (+6.9%)
- Boston Partners: 1.4% (+2.6%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-4.2% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.48 suggests fair value with growth premium. Forward P/E 20.4x stretched relative to 9% growth. Institutional flow bullish (8 buying vs 1 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $41.7B |
| Beta | 0.38 |
| 52W Range | $73.40 - $100.67 |
| Short Interest | 4.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.48 |
| Forward P/E | 20.4 |
| Current P/E | 22.2 |
| YoY Growth | 8.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.8% to -2.4% (-4.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.4pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.01x) but short-term weakness (below SMA20). RSI neutral at 50. OFD pattern: +DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.42% (CS: 33) | Weak |
| RSI_14 | 49.6 | Neutral |
| MACD Histogram | -0.01 | Bearish |
| vs SMA20 | 0.995x | Below |
| vs SMA50 | 1.007x | Above |
| vs SMA200 | 1.006x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $90.65
- **Stop Loss:** $87.49 (3.5% risk)
- **Target:** $96.97 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 158
- **Position Value:** $14,322.70
- **Portfolio %:** 14.32%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-17 (Est: $0.00)

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*